Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.

The pharmacokinetics of meropenem were studied after intravenous infusion in 13 patients grouped according to the impairment of their renal function. Creatinine clearance (CLCR) was greater than 50, 50 to 30, and less than 30 ml/min in groups I, II, and III, respectively. Two other groups, groups IV...

Повний опис

Бібліографічні деталі

Опубліковано в::	Antimicrob Agents Chemother
Автори:	Chimata, M, Nagase, M, Suzuki, Y, Shimomura, M, Kakuta, S
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology (ASM) 1993
Предмети:	Research Article
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187644/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8452352/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.229
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!